Clinical trials: Endocarditis

Q Fever

Safety Evaluation of a Q-fever Vaccine, NDBR 105

• Completed
• Age: 17 to 65 years
• Phase 2
• Vaccines
• Results posted

The purpose of this study is to evaluate the safety of Q Fever vaccine, NDBR 105, and collect data on incidence of occupational Q Fever infection in at risk personnel.

Trial name

NCT00584454

Testing

Q Fever Vaccine (NDBR 105

Where

United States

Volunteers

10 people, healthy volunteers welcome

Sponsor

U.S. Army Medical Research and Development Command